Connecticut Wealth Management LLC reduced its position in Danaher Corporation (NYSE:DHR – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,806 shares of the conglomerate’s stock after selling 2,786 shares during the quarter. Connecticut Wealth Management LLC’s holdings in Danaher were worth $1,787,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DHR. Norges Bank bought a new stake in Danaher in the fourth quarter valued at about $2,177,106,000. Viking Global Investors LP increased its holdings in Danaher by 543.9% in the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after buying an additional 2,455,994 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in Danaher by 104.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after buying an additional 2,216,789 shares during the last quarter. Generation Investment Management LLP increased its holdings in Danaher by 34.0% in the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock valued at $1,319,354,000 after buying an additional 1,689,020 shares during the last quarter. Finally, Capital International Investors increased its holdings in Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after buying an additional 1,487,768 shares during the last quarter. 79.05% of the stock is owned by institutional investors.
Danaher Stock Down 1.6%
NYSE:DHR opened at $180.65 on Friday. The firm has a market capitalization of $127.86 billion, a PE ratio of 34.94, a price-to-earnings-growth ratio of 2.45 and a beta of 0.81. The stock has a 50 day moving average of $181.15 and a 200-day moving average of $204.96. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.
Analyst Ratings Changes
Several brokerages recently weighed in on DHR. Piper Sandler began coverage on Danaher in a report on Thursday. They issued a “neutral” rating and a $200.00 price objective for the company. Morgan Stanley lowered their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Guggenheim lowered their price objective on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Argus lowered their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $233.61.
Check Out Our Latest Stock Report on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
